[Federal Register Volume 79, Number 248 (Monday, December 29, 2014)]
[Proposed Rules]
[Pages 77975-77981]
[FR Doc No: 2014-30265]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Chapter II

[Release Nos. 33-9694, 34-73891, 39-2500, IC-31389; IA-3986; File No.
S7-13-14]

List of Rules To Be Reviewed Pursuant to the Regulatory
Flexibility Act

AGENCY: Securities and Exchange Commission.

ACTION: Publication of list of rules scheduled for review.

-----------------------------------------------------------------------

SUMMARY: The Securities and Exchange Commission is publishing a list of
rules to be reviewed pursuant to Section 610 of the Regulatory
Flexibility Act. The list is published to provide the public with
notice that these rules are scheduled for review by the agency and to
invite public comment on whether the rules should be continued without
change, or should be amended or rescinded to minimize any significant
economic impact of the rules upon a substantial number of such small
entities.

DATES: Comments should be submitted by January 28, 2015.

ADDRESSES: Comments may be submitted by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/other.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number S7-13-14 on the subject line; or
     Use the Federal eRulemaking Portal (http://www.regulations.gov). Follow the instructions for submitting comments.

Paper Comments

     Send paper comments to Brent Fields, Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File No. S7-13-14. This file number
should be included on the subject line if email is used. To help us
process and review your comments more efficiently, please use only one
method. The Commission will post all comments on the Commission's
Internet Web site (http://www.sec.gov/rules/other.shtml). Comments also
are available for Web site viewing and printing in the Commission's
Public Reference Room, 100 F Street NE., Washington, DC 20549 on
official business days between the hours of 10:00 a.m. and 3:00 p.m.
All comments received will be posted without change; we do not edit
personal

identifying information from submissions. You should submit only
information that you wish to make available publicly.

FOR FURTHER INFORMATION CONTACT: Anne Sullivan, Office of the General
Counsel,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Regulatory Flexibility Act (``RFA''),
codified at 5 U.S.C. 600-611, requires an agency to review its rules
that have a significant economic impact upon a substantial number of
small entities within ten years of the publication of such rules as
final rules. 5 U.S.C. 610(a). The purpose of the review is ``to
determine whether such rules should be continued without change, or
should be amended or rescinded . . . to minimize any significant
economic impact of the rules upon a substantial number of such small
entities.'' 5 U.S.C. 610(a). The RFA sets forth specific considerations
that must be addressed in the review of each rule:
     The continued need for the rule;
     the nature of complaints or comments received concerning
the rule from the public;
     the complexity of the rule;
     the extent to which the rule overlaps, duplicates or
conflicts with other federal rules, and, to the extent feasible, with
state and local governmental rules; and
     the length of time since the rule has been evaluated or
the degree to which technology, economic conditions, or other factors
have changed in the area affected by the rule. 5 U.S.C. 610(c).
    The Securities and Exchange Commission, as a matter of policy,
reviews all final rules that it published for notice and comment to
assess not only their continued compliance with the RFA, but also to
assess generally their continued utility. When the Commission
implemented the Act in 1980, it stated that it ``intend[ed] to conduct
a broader review [than that required by the RFA], with a view to
identifying those rules in need of modification or even rescission.''
Securities Act Release No. 6302 (Mar. 20, 1981), 46 FR 19251 (Mar. 30,
1981). The list below is therefore broader than that required by the
RFA, and may include rules that do not have a significant economic
impact on a substantial number of small entities. Where the Commission
has previously made a determination of a rule's impact on small
businesses, the determination is noted on the list.
    The Commission particularly solicits public comment on whether the
rules listed below affect small businesses in new or different ways
than when they were first adopted.\1\ The rules and forms listed below
are scheduled for review by staff of the Commission during the next 12
months. The list includes 25 rules adopted by the Commission in 2003.
---------------------------------------------------------------------------

    \1\ Several of the rulemakings identified below included non-
substantive rule amendments, such as conforming cross references.
The Commission requests that commenters focus on the substantive
aspects of the rulemakings indicated in the list.
---------------------------------------------------------------------------

    Title: Transactions of Investment Companies With Portfolio and
Subadviser Affiliates
    Citation: 17 CFR 270.10f-3; 17 CFR 270.12d3-1; 17 CFR 270.17a-6; 17
CFR 270.17a-10; 17 CFR 270.17d-1; 17 CFR 270.17e-1
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule and rule amendments (i) expand the exemptions
for investment companies (``funds'') to engage in transactions with
``portfolio affiliates''--companies that are affiliated with the fund
solely as a result of the fund (or an affiliated fund) controlling them
or owning more than five percent of their voting securities and (ii)
permit funds to engage in transactions with subadvisers of affiliated
funds.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-25888 (January 14, 2003). The Commission considered
comments to the proposing release and to the Initial Regulatory
Flexibility Analysis prepared in Release No. IC-25557 (Apr. 30, 2002)
at that time.
* * * * *
    Title: Conditions for Use of Non-GAAP Financial Measures
    Citation: 17 CFR 244.100, 17 CFR 244.101, 17 CFR 244.102, and 17
CFR 229.10.
    Authority: 15 U.S.C. 77b(b), 15 U.S.C. 77f, 15 U.S.C. 77g, 15
U.S.C. 77h, 15 U.S.C. 77s(a), 15 U.S.C. 77z-3, 15 U.S.C. 78c, 15 U.S.C.
78d, 15 U.S.C. 78j, 15 U.S.C. 78l, 15 U.S.C. 78m, 15 U.S.C. 78o, 15
U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C. 7202(a), and 15 U.S.C. 7261.
    Description: The Commission adopted rules and amendments requiring
public companies that disclose or release financial information that is
calculated or presented on the basis of methodologies other than in
accordance with Generally Accepted Accounting Principles (GAAP) to
include, in that disclosure or release, a presentation of the most
directly comparable GAAP financial measure and a reconciliation of the
disclosed non-GAAP financial measure to that measure. The amendments
also provide additional guidance to registrants that include non-GAAP
financial measures in Commission filings and require registrants to
furnish to the Commission earnings releases or similar announcements on
Form 8-K.
    Prior Commission Determination Under 5 U.S.C. 610: Pursuant to
Section 605(b) of the Regulatory Flexibility Act, the Chairman of the
Commission certified that the rules and amendments would not have a
significant economic impact on a substantial number of small entities
in Release No. 33-8145 (November 5, 2002). The Commission solicited
comments concerning the impact on small entities and the RFA
certification, but received no comments. The final rule was adopted by
the Commission in Release No. 33-8176 (January 22, 2003).
* * * * *
    Title: Insider Trades During Pension Fund Blackout Periods
    Citation: 17 CFR 240.13a-11, 17 CFR 240.15d-11, 17 CFR 245.100, 17
CFR 245.101, 17 CFR 245.102, 17 CFR 245.103, and 17 CFR 245.104.
    Authority: 15 U.S.C. 78c, 15 U.S.C. 78m, 15 U.S.C. 78w(a), 15
U.S.C. 78mm, 15 U.S.C. 80a-29, 15 U.S.C. 80a-37, 15 U.S.C. 7202(a), and
15 U.S.C. 7244(a).
    Description: The Commission adopted rules and amendments to clarify
the application and prevent the evasion of Section 306(a) of the
Sarbanes-Oxley Act of 2002, which prohibits any director or executive
officer of an equity security issuer from acquiring or transferring any
equity security of the issuer during a pension plan blackout period
that temporarily prevents plan participants or beneficiaries from
engaging in equity securities transactions through their plan accounts,
if the director or executive officer acquired the equity security in
connection with his or her service or employment as a director or
executive officer. In addition, the rules specify the content and
timing of the notice that issuers must provide to their directors and
executive officers, and to the Commission about the imposition of a
pension plan blackout period.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 34-47225 (January 22, 2003). The Commission considered
comments received on the proposing release and the Initial Regulatory
Flexibility Analysis prepared in Release

No. 34-46778 (November 6, 2002) at that time.
* * * * *
    Title: Disclosure Required by Sections 406 and 407 of the Sarbanes-
Oxley Act of 2002.
    Citation: 17 CFR 229.401 and 17 CFR 229.406.
    Authority: 15 U.S.C. 77e, 15 U.S.C. 77f, 15 U.S.C. 77g, 15 U.S.C.
77j, 15 U.S.C. 77q, 15 U.S.C. 77s, 15 U.S.C. 77z-3, 15 U.S.C. 78l, 15
U.S.C. 78m, 15 U.S.C. 78o, 15 U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C.
7202(a), 15 U.S.C. 7264, and 15 U.S.C. 7265.
    Description: The Commission adopted amendments to require
companies, other than registered investment companies, to disclose
information relating to whether an audit committee financial expert
serves on the company's audit committee and the adoption and
implementation of a code of ethics that applies to its principal
executive officer, principal financial officer, principal accounting
officer or controller, or persons performing similar functions.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8177 (January 23, 2003). The Commission considered
comments received on the proposing release and the Initial Regulatory
Flexibility Analysis prepared in Release No. 33-8138 (October 22, 2002)
at that time.
* * * * *
    Title: Retention of Records Relevant to Audits and Reviews
    Citation: 17 CFR 210 2-06
    Authority: 15 U.S.C. 7202(a), 18 U.S.C. 1519, 15 U.S.C. 77g, 15
U.S.C. 77h, 15 U.S.C. 77j, 15 U.S.C. 77s, 15 U.S.C. 77z-3, 15 U.S.C.
78c, 15 U.S.C. 78j-1, 15 U.S.C. 78l, 15 U.S.C. 78m, 15 U.S.C. 78n, 15
U.S.C. 78q, 15 U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C. 80a-8, 15 U.S.C.
80a-29, 15 U.S.C. 80a-30, 15 U.S.C. 80a-31, and 15 U.S.C. 80a-37.
    Description: The rules were adopted pursuant to Section 802 of the
Sarbanes-Oxley Act of 2002 to require accounting firms to retain for
seven years certain records relevant to their audits and reviews of
issuers' financial statements. Records to be retained include an
accounting firm's workpapers and certain other documents that contain
conclusions, opinions, analyses, or financial data related to the audit
or review.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Act Analysis was prepared in accordance with
Section 604 of the Regulatory Flexibility Act in conjunction with the
adoption of Release No. 33-8189 (January 24, 2003). The Commission
considered comments to the proposing release and to the Initial
Regulatory Flexibility Analysis prepared in Release No. 33-8151
(November 21, 2002) at that time.
* * * * *
    Title: Certification of Management Investment Company Shareholder
Reports and Designation of Certified Shareholder Reports as Exchange
Act Periodic Reporting Forms; Disclosure Required by Sections 406 and
407 of the Sarbanes-Oxley Act of 2002.
    Citation: 17 CFR 270.8b-15; 17 CFR 270.30a-1; 17 CFR 270.30a-2; 17
CFR 270.30a-3; 17 CFR 270.30b1-1; 17 CFR 270.30b1-3; 17 CFR 270.30b2-1;
17 CFR 270.30d-1; 17 CFR 274.101; 17 CFR 274.128.
    Authority: 15 U.S.C. 77f, 77g, 77h, 77j, 77s, 78c(b), 78l, 78m,
78n, 78o(d), 80a-1 et seq., 80a-8, 80a-24, 80a-26, 80a-29, 80a-34(d),
80a-37, 80a-39, secs. 3(a) and 302, Pub. L. 107-204, 116 Stat. 745.
    Description: The Commission adopted rule and form amendments to
require registered management investment companies to file certified
shareholder reports on new Form N-CSR in accordance with Section 302 of
the Sarbanes-Oxley Act. The Commission also adopted new rules to
require registered investment management companies to maintain
disclosure controls and procedures, to disclose whether they had
adopted a code of ethics for their principal executive and senior
financial officers, and to disclose whether they have at least one
``audit committee financial expert'' serving on their audit committees,
as required by that Act.
    Determination Under 5 U.S.C. 601: A Final Regulatory Flexibility
Analysis was prepared in accordance with Section 604 of the Regulatory
Flexibility Act in conjunction with the adoption of Release No. IC-
25914 (January 27, 2003). The Commission considered comments to the
proposing release and to the Initial Regulatory Flexibility Analysis
prepared in Release Nos. IC-25723 (Aug. 30, 2002) and 25775 (Oct. 22,
2002) at that time.
* * * * *
    Title: Disclosure in Management's Discussion and Analysis about
Off-Balance Sheet Arrangements and Aggregate Contractual Obligations.
    Citation: 17 CFR 229.303.
    Authority: 15 U.S.C. 77g, 15 U.S.C. 77j, 15 U.S.C. 77s, 15 U.S.C.
77z-2, 15 U.S.C. 77z-3, 15 U.S.C. 78l, 15 U.S.C. 78m, 15 U.S.C. 78n, 15
U.S.C. 78u-5, 15 U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C. 7202(a), and 15
U.S.C. 7261(a).
    Description: The Commission adopted the amendments to require
disclosure of off-balance sheet arrangements in a separately captioned
subsection of the Management's Discussion and Analysis section of a
registrant's disclosure documents. The amendments also require
registrants, other than smaller reporting companies, to provide tabular
disclosure of aggregate contractual obligations as of the latest fiscal
year-end balance sheet date.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8182 (January 28, 2003). The Commission solicited
comments concerning the impact on small entities and the Initial
Regulatory Flexibility Analysis prepared in Release No. 33-8144
(November 4, 2002), but received no comments.
* * * * *
    Title: Implementation of Standards of Professional Conduct for
Attorneys
    Citation: 17 CFR part 205.
    Authority: 15 U.S.C. 7202, 7245, 7262.
    Description: The Commission adopted a rule establishing standards
of professional conduct for attorneys who appear and practice before
the Commission on behalf of issuers. Section 307 of the Sarbanes-Oxley
Act of 2002 requires the Commission to prescribe minimum standards of
professional conduct for attorneys appearing and practicing before the
Commission in any way in the representation of issuers. The rule
requires an attorney to report evidence of a material violation of
securities laws or breach of fiduciary duty or similar violation by the
issuer up-the-ladder within the company.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8185 (January 29, 2003). The Commission solicited
comments concerning the impact on small entities and the Initial
Regulatory Flexibility Analysis prepared in Release No. 33-8150 (Nov.
21, 2002), but received no comments.
* * * * *
    Title: Proxy Voting by Investment Advisers
    Citation: 17 CFR 275.204-2; 17 CFR 275.206(4)-6.

    Authority: 15 U.S.C. 80b-2(a)(11)(F), 80b-2(a)(17), 80b-3, 80b-4,
80b-6(4), 80b-6a, 80b-11.
    Description: The rule and rule amendments require investment
advisers that exercise voting authority over client securities to adopt
written policies and procedures that are reasonably designed to ensure
the adviser votes proxies in the best interest of clients, disclose to
clients information about those policies and procedures and how clients
may obtain information on how the adviser has voted their proxies, and
retain certain records relating to proxy voting.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act regarding rule 206(4)-6 and rule
204-2 under the Investment Advisers Act of 1940 in conjunction with the
adoption of Release No. IA-2106 (January 31, 2003). The Commission
considered comments to the proposing release and to the Initial
Regulatory Flexibility Analysis prepared in Release No. IA-2059
(September 20, 2002) at that time.
* * * * *
    Title: Disclosure of Proxy Voting Policies and Proxy Voting Records
by Registered Management Investment Companies
    Citation: 17 CFR 270.30b1-4; 17 CFR 274.11A; 17 CFR 274.11a-1; 17
CFR 274.11b; 17 CFR 274.128; 17 CFR 274.130.
    Authority: 15 U.S.C. 77f, 77g, 77h, 77j, 77s, 78c(b), 78l, 78m,
78n, 78o(d), 80a-1 et seq., 80a-24, 80a-26, and 80a-29, 80a-34(d), 80a-
37, 80a-39.
    Description: The rule and rule amendments require registered
management investment companies (i) to provide disclosure about how
they vote proxies relating to portfolio securities they hold, (ii) to
disclose the policies and procedures that they use to determine how to
vote proxies relating to portfolio securities, and (iii) to file with
the Commission and to make available to shareholders the specific proxy
votes that they cast in shareholder meetings of issuers of portfolio
securities.
    Determination Under 5 U.S.C. 601: A Final Regulatory Flexibility
Analysis was prepared in accordance with Section 604 of the Regulatory
Flexibility Act in conjunction with the adoption of Release No. IC-
25922 (January 31, 2003). The Commission considered comments to the
proposing release and to the Initial Regulatory Flexibility Analysis
prepared in Release No. IC-25739 (Sept. 20, 2002) at that time.
* * * * *
    Title: Custody of Investment Company Assets with a Securities
Depository
    Citation: 17 CFR 270.17f-4.
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule amendments expand the types of investment
companies that may maintain assets with a depository, and update the
conditions they must follow to use a depository. The amendments respond
to developments in securities depository practices and commercial law
since the rule was adopted.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-25934 (February 13, 2003). The Commission considered
comments to the proposing release and to the Initial Regulatory
Flexibility Analysis prepared in Release No. IC-25266 (Nov. 15, 2001)
at that time.
* * * * *
    Title: Definition of Terms in and Specific Exemptions for Banks,
Savings Associations, and Savings Banks Under Sections 3(a)(4) and
3(a)(5) of the Securities Exchange Act of 1934
    Citation: 17 CFR 240.3a5-1, 17 CFR 240.3b-18, 17 CFR 240.15a-8, and
17 CFR 240.15a-11
    Authority: 15 U.S.C. 77c, 77d, 77g, 77j, 77s, 77z-2, 77z-3, 77eee,
77ggg, 77nnn, 77sss, 77ttt, 78c, 78d, 78e, 78f, 78g, 78i, 78j, 78j-1,
78k, 78k-1, 78l, 78m, 78n, 78o, 78p, 78q, 78s, 78u-5, 78w, 78x, 78ll,
78mm, 79q, 79t, 80a-20, 80a-23, 80a-29, 80a-37, 80b-3, 80b-4, and 80b-
11.
    Description: The Commission adopted amendments to its rule granting
an exemption to banks from dealer registration for a de minimis number
of riskless principal transactions, and to its rule that defines terms
used in the bank exception to dealer registration for asset-backed
transactions. The Commission also adopted a new exemption for banks
from the definition of broker and dealer under the Securities Exchange
Act of 1934 for certain securities lending transactions. In addition,
the Commission extended the exemption from rescission liability under
Exchange Act Section 29 to contracts entered into by banks acting in a
dealer capacity before March 31, 2005. These rules addressed certain of
the exceptions for banks from the definitions of ``broker'' and
``dealer'' that were added to the Securities Exchange Act by the Gramm-
Leach-Bliley Act.
    Prior Commission Determination Under 5 U.S.C. 610: Pursuant to
Section 605(b) of the Regulatory Flexibility Act, the Commission
certified that the amendment to the rule would not have a significant
economic impact on a substantial number of small entities. This
certification was incorporated into the proposing release, Release No.
34-46745 (November 5, 2002). As stated in the adopting release, No. 34-
47364 (February 14, 2003), the Commission received no comments
concerning the impact on small entities or the Regulatory Flexibility
Act Certification.
* * * * *
    Title: Regulation Analyst Certification
    Citation: 17 CFR 242.500 through 505.
    Authority: 15 U.S.C. 77g, 77q(a), 77s(a), 78b, 78c, 78g(c)(2),
78i(a), 78j, 78k-1(c), 78l, 78m, 78mm, 78n, 78o(b), 78o(c), 78o(g),
78q(a), 78q(b), 78q(h), 78w(a), 78dd-1, 80a-23, 80a-29, and 80a-37.
    Description: Regulation Analyst Certification (``Regulation AC'')
requires that brokers, dealers, and certain persons associated with a
broker or dealer include in research reports certifications by the
research analyst that the views expressed in the report accurately
reflect his or her personal views, and disclose whether or not the
analyst received compensation or other payments in connection with his
or her specific recommendations or views. Broker-dealers are also
required to obtain periodic certifications by research analysts in
connection with the analyst's public appearances.
    Prior Commission Determination Under 5 U.S.C. 610: Pursuant to
Section 605(b) of the Regulatory Flexibility Act, the Commission
certified that Regulation AC would not have a significant economic
impact on a substantial number of small entities. This certification,
including the reasons supporting the certification, was set forth in
the proposing release, Release No. 33-8119 (August 2, 2002). The
Commission solicited comments on the potential impact of Regulation AC
on small entities in the proposing release. No comments were received
that discussed the Regulatory Flexibility Act Certification. However,
in the adopting release, Release No. 33-8193 (February 20, 2003), in
response to other comments, the Commission revised its estimates and
concluded that the total burden in hours required to comply with
proposed Regulation AC would be approximately 5.78 hours per year, per
small firm, as compared to the original estimate of two hours and two
minutes per year, per small firm.
* * * * *

    Title: Standards Relating to Listed Company Audit Committees
    Citation: 17 CFR 229.401 and 17 CFR 240.10A-3.
    Authority: 15 U.S.C. 77b, 15 U.S.C. 77f, 15 U.S.C. 77g, 15 U.S.C.
77h, 15 U.S.C. 77j, 15 U.S.C. 77q, 15 U.S.C. 77s, 15 U.S.C. 78c(b), 15
U.S.C. 78j-1, 15 U.S.C. 78l, 15 U.S.C. 78m, 15 U.S.C. 78n, 15 U.S.C.
78o, 15 U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C. 80a-8, 15 U.S.C. 80a-20,
15 U.S.C. 80a-24(a), 15 U.S.C. 80a-29, 15 U.S.C. 80a-37, and 15 U.S.C.
7202.
    Description: The Commission adopted rules to direct the national
securities exchanges and national securities associations to prohibit
the listing of any security of an issuer that is not in compliance with
the audit committee requirements mandated by the Sarbanes-Oxley Act of
2002. In addition, the Commission adopted amendments changing its
disclosure requirements regarding audit committees.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8220 (April 9, 2003). The Commission solicited
comments concerning the impact on small entities and the Initial
Regulatory Flexibility Analysis prepared in Release No. 33-8173
(January 8, 2003), but received no comments.
* * * * *
    Title: Customer Identification Programs for Mutual Funds
    Citation: 17 CFR 270.0-11
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule implements section 326 of the USA PATRIOT Act
of 2001 and requires investment companies (i) to implement procedures
to verify the identity of any person seeking to open an account, (ii)
to the extent reasonable and practicable, to maintain records of the
information used to verify the person's identity, and (iii) to
determine whether the person appears on any lists of known or suspected
terrorists or terrorist organizations provided to investment companies
by any government agency.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-26031 (April 29, 2003). The Commission considered
comments to the proposing release and to the Initial Regulatory
Flexibility Analysis prepared in Release No. 34-46192 (July 12, 2002)
at that time.
* * * * *
    Title: Improper Influence on Conduct of Audits
    Citation: 17 CFR 240 13b2-2.
    Authority: 15 U.S.C. 7202(a), 15 U.S.C. 7242, 15 U.S.C. 77e, 15
U.S.C. 77f, 15 U.S.C. 77g, 15 U.S.C. 77h, 15 U.S.C. 77j, 15 U.S.C. 77s,
15 U.S.C. 78c, 15 U.S.C. 78j-1, 15 U.S.C 78l, 15 U.S.C. 78m, 15 U.S.C.
78n, 15 U.S.C. 78o, 15 U.S.C. 78q, 15 U.S.C. 78w, 15 U.S.C. 80a-6, 15
U.S.C. 80a-8, 15 U.S.C 80a-20, 15 U.S.C. 80a-29, 15 U.S.C 80a-30, and
15 U.S.C. 80a-37.
    Description: The rules were adopted pursuant to the requirements of
Section 303 of the Sarbanes-Oxley Act of 2002 to prohibit officers and
directors of an issuer, and persons acting under the direction of an
officer or director, from taking any action to coerce, manipulate,
mislead, or fraudulently influence the auditor of the issuer's
financial statements if that person knew or should have known that such
action, if successful, could result in rendering the financial
statements materially misleading.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Act Analysis was prepared in accordance with
Section 604 of the Regulatory Flexibility Act in conjunction with the
adoption of Release No. 34-47890 (May 20, 2003). The Commission
considered comments to the proposing release and to the Initial
Regulatory Flexibility Analysis prepared in Release No. 34-46685
(October 18, 2002) at that time.
* * * * *

    Title: Management's Reports on Internal Control Over Financial
Reporting and Certification of Disclosure in Exchange Act Periodic
Reports
    Citation: 17 CFR 210.1-02, 17 CFR 210.2-02, 17 CFR 229.307, 17 CFR
229.308, 17 CFR 240.12b-15, 17 CFR 240.13a-14, 17 CFR 240.13a-15, 17
CFR 240.15d-14, 17 CFR 240.15d-15.
    Authority: 15 U.S.C. 77e, 15 U.S.C. 77f, 15 U.S.C. 77g, 15 U.S.C.
77j, 15 U.S.C. 77q, 15 U.S.C. 77s, 15 U.S.C. 78l, 15 U.S.C. 78m, 15
U.S.C. 78o, 15 U.S.C. 78w, 15 U.S.C. 78mm, 15 U.S.C. 80a-8, 15 U.S.C.
80a-29, 15 U.S.C. 80a-30, 15 U.S.C. 80a-37, 15 U.S.C. 7202(a), 15
U.S.C. 7241, 15 U.S.C. 7262, 15 U.S.C. 7263, and 18 U.S.C. 1350.
    Description: The rules and amendments were adopted in light of
Congress' directive in Section 404 of the Sarbanes-Oxley Act of 2002 to
require reporting companies, other than registered investment
companies, to include in their annual reports a report of management on
the company's internal control over financial reporting. The internal
control report must include management's assessment of the
effectiveness of the company's internal control over financial
reporting as of the end of its most recent fiscal year, as well as a
statement that the registered public accounting firm that audited the
company's financial statements included in the annual report has issued
an attestation report on management's assessment. The rules also
require companies to file the registered public accounting firm's
attestation report as part of its annual report. Further, the rules
require that management evaluate any change in the company's internal
control over financial reporting that occurred during a fiscal quarter
that has or is reasonably likely to materially affect the company's
internal control over financial reporting. In addition, the amendments
require companies to provide the certifications required by Sections
302 and 906 of the Sarbanes-Oxley Act as exhibits to certain periodic
reports.
    In 2010, the Dodd-Frank Wall Street Reform and Consumer Protection
Act amended Section 404 of the Sarbanes-Oxley Act to provide that
Section 404(b) shall not apply with respect to any audit report
prepared for an issuer that is neither an accelerated filer, nor a
large accelerated filer, as defined in Exchange Act Rule 12b-2. In
2010, the Commission adopted conforming amendments to its rules.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8238 (June 5, 2003). The Commission solicited
comments with respect to the rules and amendments in two separate
proposing releases, Release Nos. 33-8138 (October 22, 2002) and 33-8212
(March 21, 2003). The Commission also solicited comments concerning the
impact on small entities and the Initial Regulatory Flexibility
Analysis, but received no comments on the impact on small entities of
the new certification requirements.
* * * * *
    Title: Certain Research and Development Companies
    Citation: 17 CFR 270.3a-8
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule provides a nonexclusive safe harbor from the
definition of an investment company for

certain bona fide research and development companies.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-26077 (June 16, 2003). The Commission solicited
comments concerning the impact on small entities and the Initial
Regulatory Flexibility Analysis prepared in Release No. IC-25835 (Nov.
26, 2002) but received no comments.
* * * * *
    Title: Custody of Funds or Securities of Clients by Investment
Advisers
    Citation: 17 CFR 275.206(4)-2; 17 CFR 279.1
    Authority: 15 U.S.C. 80b-1 et seq., 80b-2(a)(11)(F), 80b-2(a)(17),
80b-3, 80b-4, 80b-6(4), 80b-6a, 80b-11
    Description: The amendments to the custody rule conformed the rule
to modern custodial practices and required advisers that have custody
of client funds or securities to maintain those assets with broker-
dealers, banks, or other qualified custodians. The amendments were
designed to enhance protections for client assets while reducing
burdens on advisers that have custody of client assets.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act with respect to amended rule
206(4)-2 under the Advisers Act and to amended Part 1A, Item 9 and Part
II, Item 14 of Form ADV in conjunction with the adoption of Release No.
IA- 2176 (September 25, 2003). The Commission solicited comments
concerning the impact on small entities and the Initial Regulatory
Flexibility Analysis prepared in Release No. IA-2044 (July 18, 2002),
but received no comments.
* * * * *
    Title: Amendments to Investment Company Advertising Rules
    Citation: 17 CFR 270.34b-1
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule amendments (i) require enhanced disclosure in
investment company advertisements to encourage advertisements that
convey balanced information to prospective investors, particularly with
respect to past performance, and (ii) implement section 24(g) of the
Investment Company Act by permitting the use of a prospectus under
section 10(b) of the Securities Act with respect to securities issued
by an investment company that includes information the substance of
which is not included in the investment company's statutory prospectus.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-26195 (September 29, 2003). The Commission considered
comments to the proposing release and to the Initial Regulatory
Flexibility Analysis prepared in Release No. IC-25575 (May 17, 2002) at
that time.
* * * * *
    Title: Purchases of Certain Equity Securities by the Issuer and
Others
    Citation: 17 CFR 228.703; 17 CFR 229.703; 17 CFR 240.10b-18; 17 CFR
249.220f; 17 CFR 249.308a; 17 CFR 249.308b; 17 CFR 249.310; 17 CFR
249.310b; 17 CFR 249.33117 CFR 270.23c-1; 17 CFR 274.128; 17 CFR
274.201
    Authority: 15 U.S.C. 77f, 77g, 77h, 77j, 77K, 77s, 77z-2, 77z-3,
77aa(25), 77aa(26), 77ddd, 77eee, 77ggg, 77hhh, 77iii, 77jjj, 77nnn,
77sss, 77ttt, 78c, 78c(b),), 78d, 78i, 78j, 78j-1, 78k, 78k-1, 78l,
78l, 78m, 78n, 78o, 78p, 78q, 78s, 78l, 78m, 78n, 78o(d), 78u-5, 78w,
78x, 78ll, 78mm, 79e, 79j, 79n, 79q, 79t, 80a-1 et seq., 80a-8, 80a-9,
80a-20, 80a-23, 80a-24, 80a-26, 80a-29, 80a-30, 80a-24, 80a-26, 80a-29,
80a-34(d), 80a-38(a), 80a-37, 80a-39, 80b-3, 80b-4, 80b-11, 7201 et
seq., 18 U.S.C. 1350.
    Description: The rule amendments provide issuers with a ``safe
harbor'' from liability for manipulation when they repurchase their
common stock in the market in accordance with the rule's manner,
timing, price, and volume conditions. The amendments are intended to
simplify and update the safe harbor provisions in light of market
developments since the rule's adoption. To enhance the transparency of
issuer repurchases, the Commission also adopted amendments to a number
of regulations and forms regarding disclosure of repurchases of equity
securities by the issuer and affiliated purchasers (both open market
and private transactions), regardless of whether the repurchases are
effected in accordance with the issuer repurchase safe harbor rule.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 33-8335 (November 10, 2003). The Commission solicited
comments concerning the impact on small entities and the Initial
Regulatory Flexibility Analysis prepared in Release No. 34-46980
(December 10, 2002), but received no comments.
* * * * *
    Title: Disclosure Regarding Nominating Committee Functions and
Communications Between Security Holders and Boards of Directors
    Citation: 17 CFR 270.30a-2; 17 CFR 274.128
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39.
    Description: The rule amendments impose new disclosure requirements
and amendments to existing disclosure requirements to enhance the
transparency of the operations of boards of directors. Specifically,
the Commission adopted enhancements to existing disclosure requirements
regarding the operations of board nominating committees and a new
disclosure requirement concerning the means, if any, by which security
holders may communicate with directors. These rules require disclosure
but do not mandate any particular action by a company or its board of
directors; rather, the new disclosure requirements are intended to make
more transparent to security holders the operation of the boards of
directors of the companies in which they invest.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. IC-26262 (November 24, 2003). The Commission solicited
comments on the proposing release and on the Initial Regulatory
Flexibility Analysis prepared in Release No. 34-48301 (August 8, 2003).
The Commission received no comments on the Initial Regulatory
Flexibility Analysis, but it did receive comments on the impact of the
proposed rules on small business issuers. The Commission considered
those comments in the adopting release.
* * * * *
    Title: Processing Requirements for Cancelled Security Certificates
    Citation: 17 CFR 240.17f-1, 17 CFR 240.17Ad-7, 17 CFR 240.17Ad-12,
and 17 CFR 240.17Ad-19
    Authority: 15 U.S.C. 77c, 77d, 77g, 77j, 77s, 77z-2, 77z-3, 77eee,
77ggg, 77nnn, 77sss, 77ttt, 78c, 78d, 78e, 78f, 78g, 78i, 78j, 78j-1,
78k, 78k-1, 78l, 78m, 78n, 78o, 78p, 78q, 78s, 78u-5, 78w, 78x, 78ll,
78mm, 79q, 79t, 80a-20, 80a-23, 80a-29, 80a-37, 80b-3, 80b-4, 80b-11,
7202, 7241, 7262, and 7263, and 18 U.S.C. 1350.

    Description: This rule requires every transfer agent to establish
and implement written procedures for the cancellation, storage,
transportation, destruction, or other disposition of securities
certificates. The rule requires transfer agents to mark each cancelled
securities certificate with the word ``cancelled''; maintain a secure
storage area for cancelled certificates; maintain a retrievable
database of all cancelled, destroyed, or otherwise disposed of
certificates; and have specific procedures for the destruction of
cancelled certificates. Additionally, the Commission amended its lost
and stolen securities rule and its transfer agent safekeeping rule to
make it clear that these rules apply to unissued and cancelled
certificates.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with the adoption
of Release No. 34-48931 (December 16, 2003). The Commission solicited
comment on the Initial Regulatory Flexibility Analysis prepared in the
proposing release, Release No. 34-43401 (October 2, 2000), but received
no comment on that analysis. The Commission did receive comments
related to small business, and considered those comments in the
adopting release.
* * * * *
    Title: Compliance Programs of Investment Companies and Investment
Advisers
    Citation: 17 CFR 270.38a-1; 17 CFR 275.204-2; 17 CFR 275.206(4)-7
    Authority: 15 U.S.C. 80a-1 et seq., 80a-34(d), 80a-37, 80a-39, 80b-
1 et seq., 80b-2(a)(11)(F), 80b-2(a)(17), 80b-3, 80b-4, 80b-6(4), 80b-
6a, 80b-11
    Description: The rules require each investment company and
investment adviser registered with the Commission and each business
development company to (i) adopt and implement written compliance
policies and procedures, (ii) review those policies and procedures
annually, and (iii) appoint a compliance officer to be responsible for
administering the policies and procedures. The rules also impose a new
recordkeeping requirement.
    Prior Commission Determination Under 5 U.S.C. 601: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act regarding rule 38a-1 under the
Investment Company Act of 1940, new rule 206(4)-7 under the Investment
Advisers Act, and amendments to rule 204-2 under the Investment
Advisers Act, and to Part 1, Schedule A, Item 2(a) of Form ADV in
conjunction with the Commission's adoption of Release No. IA-2204
(December 17, 2003). The Commission considered comments on the
proposing release and on the Initial Regulatory Flexibility Analysis
prepared in Release No. IC-25925 (Feb. 5, 2003) at that time.
* * * * *
    Title: Recordkeeping Requirements for Registered Transfer Agents
    Citation: 17 CFR 240. 240.17Ad-7
    Authority: 15 U.S.C. 77c, 77d, 77g, 77j, 77s, 77z-2, 77z-3, 77eee,
77ggg, 77nnn, 77sss, 77ttt, 78c, 78d, 78e, 78f, 78g, 78i, 78j, 78j-1,
78k, 78k-1, 78l, 78m, 78n, 78o, 78p, 78q, 78s, 78u-5, 78w, 78x, 78ll,
78mm, 79q, 79t, 80a-20, 80a-23, 80a-29, 80a-37, 80b-3, 80b-4, 80b-11,
7202, 7241, 7262, and 7263, and 18 U.S.C. 1350.
    Description: The Commission amended its rule concerning
recordkeeping requirements for registered transfer agents. The
amendments made it clear that registered transfer agents may use
electronic, microfilm, and microfiche media as a substitute for hard
copy records, including cancelled stock certificates, for purposes of
complying with the Commission's transfer agent recordkeeping rules and
that a third party on behalf of a registered transfer agent may place
into escrow the required software information.
    Prior Commission Determination Under 5 U.S.C. 610: A Final
Regulatory Flexibility Analysis was prepared in accordance with Section
604 of the Regulatory Flexibility Act in conjunction with Release No.
34-48949 (December 18, 2003). The Commission received comment letters
in response to the Initial Regulatory Flexibility Analysis in the
proposing release, Release No. 34-48036 (June 16, 2003), that did not
address the issues presented in the proposing release.

    By the Commission.

    Dated: December 19, 2014.
Brent J. Fields,
Secretary.
[FR Doc. 2014-30265 Filed 12-24-14; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 83, Number 206 (Wednesday, October 24, 2018)]
[Notices]
[Page 53740]
[FR Doc No: 2018-23226]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2018-0206]

Qualification of Drivers; Exemption Applications; Diabetes

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of denials.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to deny applications from seven
individuals who requested an exemption from the Federal Motor Carrier
Safety Regulations (FMCSRs) prohibiting persons with insulin-treated
diabetes mellitus (ITDM) from operating a commercial motor vehicle
(CMV) in interstate commerce.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER>, [email protected], FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Services, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to http://www.regulations.gov.
Insert the docket number, FMCSA-2018-0206, in the keyword box, and
click ``Search.'' Next, click the ``Open Docket Folder'' button and
choose the document to review. If you do not have access to the
internet, you may view the docket online by visiting the Docket
Management Facility in Room W12-140 on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9
a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays.

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

II. Background

    FMCSA received applications from seven individuals who requested an
exemption from the FMCSRs prohibiting persons with ITDM from operating
a CMV in interstate commerce.
    FMCSA has evaluated the eligibility of these applicants and
concluded that granting these exemptions would not provide a level of
safety that would be equivalent to or greater than, the level of safety
that would be obtained by complying with the regulation 49 CFR
391.41(b)(3).

III. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption if
it finds such an exemption would likely achieve a level of safety that
is equivalent to, or greater than, the level that would be achieved
absent such an exemption.
    The Agency's decision regarding these exemption applications is
based on the eligibility criteria, the terms and conditions for Federal
exemptions, and an individualized assessment of each applicant's
medical information provided by the applicant.

IV. Conclusion

    The Agency has determined that these applicants do not satisfy the
criteria eligibility or meet the terms and conditions of the Federal
exemption and granting these exemptions would not provide a level of
safety that would be equivalent to or greater than, the level of safety
that would be obtained by complying with the regulation 49 CFR
391.41(b)(3). Therefore, the seven applicants in this notice have been
denied exemptions from the physical qualification standards in 49 CFR
391.41(b)(3).
    Each applicant has, prior to this notice, received a letter of
final disposition regarding his/her exemption request. Those decision
letters fully outlined the basis for the denial and constitutes final
action by the Agency. This notice summarizes the Agency's recent
denials as required under 49 U.S.C. 31315(b)(4) by periodically
publishing names and reasons for denial.
    The following four applicants met the diabetes requirements of 49
CFR 391.41(b)(3) and do not need an exemption:

Randal B. Bivin (TX)
Joel D. Dillahunty (TX)
Donald D. Gueiss (NC)
Kurt A. Taranto (NY)

    The following two applicants had other medical conditions making
the applicant otherwise unqualified under the Federal Motor Carrier
Safety Regulations Norman C. Hutchinson, (IA); Curtis D. Lansdell,
(AR).
    The following applicant, David L. Fisher (PA), did not have
endocrinologists willing to make statements that he is able to operate
CMVs from a diabetes standpoint.

     Issued on: October 15, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-23226 Filed 10-23-18; 8:45 am]
 BILLING CODE 4910-EX-P


[Federal Register Volume 80, Number 97 (Wednesday, May 20, 2015)]
[Rules and Regulations]
[Pages 28839-28843]
[FR Doc No: 2015-11959]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2013-0821; FRL-9927-38]

Fragrance Components; Exemption From the Requirement of a
Tolerance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of various fragrance component substances
when used as inert ingredients in antimicrobial pesticide formulations
for use on food contact surfaces in public eating places, dairy-
processing equipment, and food-processing equipment and utensils. This
regulation eliminates the need to establish a maximum permissible level
for residues of these various fragrance component substances

DATES: This regulation is effective May 20, 2015. Objections and
requests for hearings must be received on or before July 20, 2015, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2013-0821, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, and the telephone number for the OPP
Docket is<PHONE_NUMBER>. Please review the visitor instructions and
additional information about the docket available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Susan Lewis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone
number:<PHONE_NUMBER>; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. How can I get electronic access to other related information?

    You may access a frequently updated electronic version of 40 CFR
part 180 through the Government Publishing Office's e-CFR site at
http://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.

C. How can I file an objection or hearing request?

    Under the Federal Food, Drug, and Cosmetic Act (FFDCA) section
408(g), 21 U.S.C. 346a, any person may file an objection to any aspect
of this regulation and may also request a hearing on those objections.
You must file your objection or request a hearing on this regulation in
accordance with the instructions provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must identify docket ID number EPA-HQ-OPP-
2013-0821 in the subject line on the first page of your submission. All
objections and requests for a hearing must be in writing, and must be

received by the Hearing Clerk on or before July 20, 2015. Addresses for
mail and hand delivery of objections and hearing requests are provided
in 40 CFR 178.25(b).
    In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2013-0821, by one of
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.

II. Today's Action

A. What is the authority for this action?

    EPA is taking this action under section 408(e) the FFDCA, 21 U.S.C.
346a(e), which allows EPA to establish a tolerance exemption under
FFDCA section 408, 21 U.S.C. 346a et se. Section 408(c)(2)(A)(i) of
FFDCA allows EPA to establish an exemption from the requirement for a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the exemption is ``safe.'' Section
408(c)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Pursuant to FFDCA section 408(c)(2)(B), in establishing or maintaining
in effect an exemption from the requirement of a tolerance, EPA must
take into account the factors set forth in FFDCA section 408(b)(2)(C),
which requires EPA to give special consideration to exposure of infants
and children to the pesticide chemical residue in establishing a
tolerance and to ``ensure that there is a reasonable certainty that no
harm will result to infants and children from aggregate exposure to the
pesticide chemical residue. . . . ''
    EPA performs a number of analyses to determine the risks from
aggregate exposure to pesticide residues. For further discussion of the
regulatory requirements of FFDCA section 408 and a complete description
of the risk assessment process, see http://www.epa.gov/pesticides/regulating/tolerances.htm.

B. What action is the Agency taking?

    EPA, on its own initiative under FFDCA section 408(e), is
establishing exemptions from the requirement of a tolerance for
residues of various fragrance component substances identified at the
end of this document.

III. EPA's Proposal

    In the Federal Register of July 25, 2014 (79 FR 43350) (FRL-9910-
53), EPA proposed, on its own initiative under FFDCA section 408(e), 21
U.S.C. 346a(e), to establish exemptions from the requirement of a
tolerance for residues of acetaldehyde (CAS Reg. No. 75-07-0), acetic
acid (CAS Reg. No. 64-19-7), allyl cyclohexyl propionate (CAS Reg. No.
2705-87-5), butryic acid (CAS Reg. No. 107-92-6), butyl alcohol (CAS
Reg. No. 71-36-3), citral (CAS Reg. No. 5392-40-5), citronellol (CAS
Reg. No. 106-22-9), citronellyl acetate (CAS Reg. No. 150-84-5),
[beta]-damascone, (Z)-(CAS Reg. No. 23726-92-3), decanal (CAS Reg. No.
112-31-2), (E)-4-decenal (CAS Reg. No. 65405-70-1), decanoic acid (CAS
Reg. No. 334-48-5), 1-decanol (CAS Reg. No. 112-30-1), 2,6-dimethyl-5-
heptanal (CAS Reg. No. 106-72-9), 2-dodecanol, (2E)- (CAS Reg. No.
20407-84-5), d-limonene (CAS Reg. No. 5989-27-5), ethyl 2-
methylbutyrate (CAS Reg. No. 452-79-1), (E)-geraniol (CAS Reg. No. 106-
24-1), (E)-geraniol acetate (CAS Reg. No. 105-87-3), heptanal (CAS Reg.
No. 111-71-7), heptanoic acid (CAS Reg. No. 111-14-8), heptyl alcohol
(CAS Reg. No. 111-70-6), hexanal (CAS Reg. No. 66-25-1), hexanoic acid
(CAS Reg. No. 142-62-1), (Z)-3-hexenol (CAS Reg. No. 928-96-1), (Z)-3-
hexenol acetate (CAS Reg. No. 3681-71-8), hexyl acetate (CAS Reg. No.
142-92-7), hexyl alcohol (CAS Reg. No. 111-27-3), lauric acid (CAS Reg.
No.143-07-7), lauric aldehyde (CAS Reg. No. 112-54-9), lauryl alcohol
(CAS Reg. No. 112-53-8), methyl-[alpha]-ionone (CAS Reg. No. 127-42-4),
3-methyl-2-butenyl acetate (CAS Reg. No. 1191-16-8), 2-methylundecanal
(CAS Reg. No. 110-41-8), myristaldehyde (CAS Reg. No. 124-25-4),
myristic acid (CAS Reg. No. 544-63-8), neryl acetate (CAS Reg. No. 141-
12-8), n-hexanol (CAS Reg. No. 111-27-3), nonanal (CAS Reg. No. 124-19-
6), nonanoic acid (CAS Reg. No. 112-05-0), nonyl alcohol (CAS Reg. No.
143-08-8), octanal (CAS Reg. No. 124-13-0), octanoic acid (CAS Reg. No.
124-07-2), 1-octanol (CAS Reg. No. 111-87-5), palmitic acid (CAS Reg.
No. 57-10-3), propionic acid (CAS Reg. No. 79-09-4), stearic acid (CAS
Reg. No. 57-11-4), 2-tridecanal (CAS Reg. No. 7774-82-5), 3,5,5-
trimethylhexanal (CAS Reg. No. 5435-64-3), undecanal (CAS Reg. No. 112-
44-7), undecyl alcohol (CAS Reg. No. 112-42-5), valeraldehyde (CAS Reg.
No. 110-62-3), and valeric acid (CAS Reg. No. 109-52-4) when used as
fragrance components (i.e., inert ingredients) in antimicrobial
pesticide formulations for use on food-contact surfaces in public
eating places, dairy-processing equipment, and food-processing
equipment and utensils at end-use concentrations not to exceed 100
parts per million (ppm).
    As discussed in that document, EPA has reviewed the available
scientific data and other relevant information in support of this
action, consistent with FFDCA section 408(c)(2), and the factors
specified in FFDCA section 408(b)(2)(C and D). EPA has sufficient data
to assess the hazards of and to make a determination on aggregate
exposure for these various fragrance components including exposure
resulting from the exemptions from the requirement of a tolerance
established by this action. For a detailed discussion of the aggregate
risk assessments and determination of safety that support the
establishment of these exemptions from the requirement of a tolerance,
please refer to the July 25, 2014 Federal Register final rule and its
supporting documents, available at http://regulations.gov.

IV. Public Comments

    EPA received nine comments to the proposed rule. Six of the
comments were fully supportive of the proposed rule. One comment made
specific reference to the fragrance component acetaldehyde and stated
that the risk assessment of acetaldehyde should reconsider the
compound's cancer risk. The comment noted that part of the safety
finding for the fragrance components was based on no structural alerts
for genotoxicity or carcinogenicity but in the case of acetaldehyde EPA
had previously considered acetaldehyde to

be a probable human carcinogen based on inadequate human cancer studies
and animal studies that have shown increased incidence of nasal tumors
in rats and laryngeal tumors in hamsters after inhalation exposure. The
Agency agrees with the commenter that the safety analysis provided in
the proposed rule, which relies on human exposure threshold values for
non-cancer risks, is not applicable to acetaldehyde and therefore,
cannot be used to support an exemption for acetaldehyde. As such, EPA
is not establishing in this final rule an exemption from the
requirement of a tolerance for acetaldehyde as a fragrance component
for use in antimicrobial pesticide formulations for use on food-contact
surfaces in public eating places, dairy-processing equipment, and food-
processing equipment and utensils at end-use concentrations not to
exceed 100 ppm.
    Two comments made reference to fragrance sensitivity among certain
individuals. The Agency understands the commenter's concerns, however
the legal framework provided by FFDCA section 408 states that
tolerances may be set when the pesticide chemical meets the safety
standard imposed by that statute. The Agency is required by FFDCA
section 408 to estimate the risk of the potential exposure to these
residues. Neither the supporting information cited by the commenters or
other reliable data demonstrate the occurrence of specific adverse
effects directly attributable to exposures to the substances listed in
Unit III and EPA has concluded that there is a reasonable certainty
that no harm will result to the general population and to infants and
children from aggregate exposure to the fragrance components listed in
Unit III when used as inert ingredients in antimicrobial formulations
for use on food contact surfaces in public eating places, dairy
processing equipment, and food processing equipment and utensils at
end-use concentrations not to exceed 100 ppm.

V. Final Rule and Determination of Safety

    Except for the exclusion of acetaldehyde, EPA is not making any
changes to the risk assessment or final rule text that was proposed in
July 25, 2014 Federal Register. Therefore, EPA concludes that there is
a reasonable certainty that no harm will result to the general
population and to infants and children from aggregate exposure to
acetic acid; allyl cylcohexylpropionate; butryic acid; butyl alcohol;
citral; citronellol; citronellyl acetate; [beta]-damascone, (Z)-;
decanal; (E)-4-decenal; decanoic acid; 1-decanol; 2,6-dimethyl-5-
heptanal; 2-dodecanol, (2E)-; d-limonene; ethyl 2-methylbutyrate; (E)-
geraniol; (E)-geraniol acetate; heptanal; heptanoic acid; heptyl
alcohol; hexanal; hexanoic acid; (Z)-3-hexenol; (Z)-3-hexenol acetate;
hexyl acetate; hexyl alcohol; lauric acid; lauric aldehyde; lauryl
alcohol; methyl-[alpha]-ionone; 3-methyl-2-butenyl acetate; 2-
methylundecanal; myristaldehyde; myristic acid; neryl acetate; n-
hexanol; nonanal; nonanoic acid; nonyl alcohol; octanal; octanoic acid;
1-octanol; palmitic acid; propionic acid; stearic acid; 2-tridecanal;
3,5,5-trimethylhexanal; undecanal; undecyl alcohol; valeraldehyde; and
valeric acid residues when used as when used as fragrance components
(i.e., inert ingredients) in antimicrobial pesticide formulations for
use on food-contact surfaces in public eating places, dairy-processing
equipment, and food-processing equipment and utensils at end-use
concentrations not to exceed 100 ppm.

VI. Other Considerations

A. Analytical Enforcement Methodology

    An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption from the requirement of a
tolerance without any numerical limitation.

B. International Residue Limits

    In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
    The Codex has not established a MRL for the fragrance components
listed in Unit II above.

VII. Conclusion

    Therefore, exemptions from the requirement of a tolerance are
established for residues of acetic acid (CAS Reg. No. 64-19-7), allyl
cyclohexyl propionate (CAS Reg. No. 2705-87-5), butryic acid (CAS Reg.
No. 107-92-6), butyl alcohol (CAS Reg. No. 71-36-3), citral (CAS Reg.
No. 5392-40-5), citronellol (CAS Reg. No. 106-22-9), citronellyl
acetate (CAS Reg. No. 150-84-5), [beta]-damascone, (Z)- (CAS Reg. No.
23726-92-3), decanal (CAS Reg. No. 112-31-2), (E)-4-decenal (CAS Reg.
No. 65405-70-1), decanoic acid (CAS Reg. No. 334-48-5), 1-decanol (CAS
Reg. No. 112-30-1), 2,6-dimethyl-5-heptanal (CAS Reg. No. 106-72-9), 2-
dodecanol, (2E)- (CAS Reg. No. 20407-84-5), d-limonene (CAS Reg. No.
5989-27-5), ethyl 2-methylbutyrate (CAS Reg. No. 452-79-1), (E)-
geraniol (CAS Reg. No. 106-24-1), (E)-geraniol acetate (CAS Reg. No.
105-87-3), heptanal (CAS Reg. No. 111-71-7), heptanoic acid (CAS Reg.
No. 111-14-8), heptyl alcohol (CAS Reg. No. 111-70-6), hexanal (CAS
Reg. No. 66-25-1), hexanoic acid (CAS Reg. No. 142-62-1), (Z)-3-hexenol
(CAS Reg. No. 928-96-1), (Z)-3-hexenol acetate (CAS Reg. No. 3681-71-
8), hexyl acetate (CAS Reg. No. 142-92-7), hexyl alcohol (CAS Reg. No.
111-27-3), lauric acid (CAS Reg. No. 143-07-7), lauric aldehyde (CAS
Reg. No. 112-54-9), lauryl alcohol (CAS Reg. No. 112-53-8), methyl-
[alpha]-ionone (CAS Reg. No. 127-42-4), 3-methyl-2-butenyl acetate (CAS
Reg. No. 1191-16-8), 2-methylundecanal (CAS Reg. No. 110-41-8),
myristaldehyde (CAS Reg. No. 124-25-4), myristic acid (CAS Reg. No.
544-63-8), neryl acetate (CAS Reg. No. 141-12-8), n-hexanol (CAS Reg.
No. 111-27-3), nonanal (CAS Reg. No. 124-19-6), nonanoic acid (CAS Reg.
No. 112-05-0), nonyl alcohol (CAS Reg. No. 143-08-8), octanal (CAS Reg.
No. 124-13-0), octanoic acid (CAS Reg. No. 124-07-2), 1-octanol (CAS
Reg. No. 111-87-5), palmitic acid (CAS Reg. No. 57-10-3), propionic
acid (CAS Reg. No. 79-09-4), stearic acid (CAS Reg. No. 57-11-4), 2-
tridecanal (CAS Reg. No. 7774-82-5), 3,5,5-trimethylhexanal (CAS Reg.
No. 5435-64-3), undecanal (CAS Reg. No. 112-44-7), undecyl alcohol (CAS
Reg. No. 112-42-5), valeraldehyde (CAS Reg. No. 110-62-3), and valeric
acid (CAS Reg. No. 109-52-4) when used as fragrance components (i.e.,
inert ingredients) in antimicrobial pesticide formulations for use on
food-contact surfaces in public eating places, dairy-processing
equipment, and food-processing equipment and utensils at end-use
concentrations not to exceed 100 ppm.

 VIII. Statutory and Executive Order Reviews

    This action establishes exemptions from the requirement of a
tolerance under FFDCA section 408(e). The Office

of Management and Budget (OMB) has exempted tolerance actions from
review under Executive Orders 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993) and 13563, entitled Improving
Regulation and Regulatory Review (76 FR 3821, January 21, 2011). As a
result, this action is not subject to Executive Order 13211, entitled
Actions Concerning Regulations That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May 22, 2001). Nor does it require
OMB review or any Agency action under Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997).
    This action does not contain any information collections subject to
OMB approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et
seq.); does not require any special considerations under Executive
Order 12898, entitled Federal Actions to Address Environmental Justice
in Minority Populations and Low-Income Populations (59 FR 7629,
February 16, 1994); and does not involve any technical standards that
would require Agency consideration of voluntary consensus standards
pursuant to section 12(d) of the National Technology Transfer and
Advancement Act (NTTAA) (15 U.S.C. 272 note).
    This action directly regulates growers, food processors, food
handlers, and food retailers, but it does not regulate State or tribal
governments. Nor does this action alter the relationships or
distribution of power and responsibilities established by Congress in
the preemption provisions of FFDCA section 408(n)(4). Therefore, the
Agency has determined that Executive Orders 13132, entitled Federalism
(64 FR 43255, August 10, 1999) and 13175, entitled Consultation and
Coordination with Indian Tribal Governments (65 FR 67249, November 9,
2000) do not apply to this action. In addition, this action does not
impose any enforceable duty, contain any unfunded mandate, or otherwise
significantly or uniquely affect small governments as described in the
Unfunded Mandates Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
    Under the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et seq.),
the Agency hereby certifies that this action will not have significant
negative economic impact on a substantial number of small entities.
Establishing an exemption from the requirement of a pesticide tolerance
is, in effect, the removal of a regulatory restriction on pesticide
residues in food and thus such an action will not have any negative
economic impact on any entities, including small entities.

X. Congressional Review Act

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.

    Dated: May 8, 2015.
G. Jeffrey Herndon,
Director, Registration Division, Office of Pesticide Programs.
    Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority:  21 U.S.C. 321(q), 346a and 371.

0
2. In Sec.  180.940, revise the entry for ``Acetic acid'' and
alphabetically add the following inert ingredients to the table in
paragraph (a) to read as follows:

Sec.  180.940  Tolerance exemptions for active and inert ingredients
for use in antimicrobial formulations (Food-contact surface sanitizing
solutions).

* * * * *
    (a) * * *

----------------------------------------------------------------------------------------------------------------
              Pesticide chemical                 CAS Reg. No.                        Limits
----------------------------------------------------------------------------------------------------------------
Acetic acid...................................         64-19-7  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Allyl cylcohexylpropionate....................       2705-87-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Butryic acid..................................        107-92-6  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Butyl alcohol.................................         71-36-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Citral........................................       5392-40-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Citronellol...................................        106-22-9  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Citronellyl acetate...........................        150-84-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
[beta]-Damascone, (Z)-........................      23726-92-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Decanal.......................................        112-31-2  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
(E)-4-Decenal.................................      65405-70-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Decanoic acid.................................        334-48-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
1-Decanol.....................................        112-30-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
2,6-Dimethyl-5-heptanal.......................        106-72-9  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
2-Dodecanol, (2E)-............................      20407-84-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Ethyl 2-methylbutyrate........................        452-79-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
(E)-Geraniol..................................        106-24-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
(E)-Geraniol acetate..........................        105-87-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Heptanal......................................        111-71-7  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Heptanoic acid................................        111-14-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

Heptyl alcohol................................        111-70-6  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Hexanal.......................................         66-25-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Hexanoic acid.................................        142-62-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
n-Hexanol.....................................        111-27-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
(Z)-3-Hexenol.................................        928-96-1  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
(Z)-3-Hexenol acetate.........................       3681-71-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Hexyl acetate.................................        142-92-7  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Lauric acid...................................        143-07-7  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Lauric aldehyde...............................        112-54-9  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Lauryl alcohol................................        112-53-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
d-Limonene....................................       5989-27-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Methyl-[alpha]-ionone.........................        127-42-4  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
3-Methyl-2-butenyl acetate....................       1191-16-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
2-Methylundecanal.............................        110-41-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Myristaldehyde................................        124-25-4  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Myristic acid.................................        544-63-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Neryl acetate.................................        141-12-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Nonanal.......................................        124-19-6  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Nonanoic acid.................................        112-05-0  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Nonyl alcohol.................................        143-08-8  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Octanal.......................................        124-13-0  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Octanoic acid.................................        124-07-2  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
1-Octanol.....................................        111-87-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Palmitic acid.................................         57-10-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Propionic acid................................         79-09-4  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
Stearic acid..................................         57-11-4  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
2-Tridecanal..................................       7774-82-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
3,5,5-Trimethylhexanal........................       5435-64-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Undecanal.....................................        112-44-7  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Undecyl alcohol...............................        112-42-5  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Valeraldehyde.................................        110-62-3  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.
Valeric acid..................................        109-52-4  When ready for use, the end-use concentration is
                                                                 not to exceed 100 ppm.

                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------

* * * * *
[FR Doc. 2015-11959 Filed 5-19-15; 8:45 am]
 BILLING CODE 6560-50-P